This sustained result is a testament to the therapys ability to address the biological drivers of hunger and metabolic dysfunction
Dual GLP-1/GIP agonist tirzepatide has exhibited impressive histological benefits including both MASH resolution and fibrosis improvement rates exceeding 50% in phase 2 studies
Pre-procedural preparation Patient evaluation: history, physical exam, imaging (echocardiogram, chest X-ray), labs (electrolytes, coagulation, kidney function) Optimization of medications (anticoagulation, etc.) Informed consent, explain risks & benefits Device selection: leads, generator, lead types Sterile prep and prophylactic antibiotics 2
For example, working closely with a health coach or fellow program participants
Q: What makes GLP-1 better than fat burners